The Effect of Exogenous Glucocorticoids on Plasma Catecholamines and Metanephrines in Patients Without Phaeochromocytomas

Abstract

The aim of the study was to evaluate the effects of steroid administration under standardised conditions in a range of patients both normal and with adrenal pathologies and to review the impact on plasma catecholamines and metanephrines. Corticosteroid administration has been linked to the development of hypertensive crises in patients with phaeochromocytoma, however a mechanism for this is not fully understood. We aimed to add useful information about the effect of steroids on levels of these hormones under usual circumstances. A prospective, observational cohort study of 50 patients undergoing the low-dose dexamethasone suppression test (LDDST) was undertaken. Additional blood samples were taken at the start and end of the standard LDDST. Biochemical analysis was carried out for plasma catecholamines and plasma free metanephrines. Demographic and hormonal data were acquired from review of the notes or measured at baseline. No significant changes in plasma catecholamines or metanephrines were seen at the end of the LDDST compared to baseline. This was also true of subgroup analysis, divided by age, gender, or type of underlying pathology. Our results suggest that hypertensive reaction responses, rare as they are, are unlikely to be related to normal adrenal physiology. Thus LDDST is likely to be safe under most circumstances, however caution should be exercised in patients with adrenal masses with imaging characteristics compatible with phaeochromocytoma. It may be prudent to defer glucocorticoid administration until functioning phaeochromocytoma has been excluded biochemically.

Key words

steroid - hydrocortisone - phaeochromocytoma - adrenals - catecholamines - metanephrines

References

• 1 Lenders JW, Keiser HR, Goldstein D, Willemsen JJ, Friberg P, Jacobs MC, Kloppenborg PW, Thien T, Eisenhofer G. Plasma metanephrines in the diagnosis of pheochromocytoma.  Ann Intern Med. 1995;  123 101-109
• 2 Eisenhofer G, Rivers G, Rosas AL, Quezado Z, Manger WM, Pacak K. Adverse drug reactions in patients with phaeochromocytoma: incidence, prevention and management.  Drug Saf. 2007;  30 1031-1062
• 3 Rosas AL, Kasperlik-Zaluska AA, Papierska L, Bass BL, Pacak K, Eisenhofer G. Pheochromocytoma crisis induced by glucocorticoids: a report of four cases and review of the literature.  Eur J Endocrinol. 2008;  158 423-429
• 4 Takahashi N, Shimada T, Tanabe K, Yoshitomi H, Murakami Y, Ishibashi Y, Kikkawa R, Yano S, Araki A, Inoue A. Steroid-induced crisis and rhabdomyolysis in a patient with pheochromocytoma: A case report and review.  Int J Cardiol. 2008;  DOI: doi: 10.1016/j.ijcard.2009.12.183
• 5 Ehrhart-Bornstein M, Hinson JP, Bornstein SR, Scherbaum WA, Vinson GP. Intraadrenal interactions in the regulation of adrenocortical steroidogenesis.  Endocr Rev. 1998;  19 101-143
• 6 Sharara-Chami RI, Joachim M, Pacak K, Majzoub JA. Glucocorticoid treatment – effect on adrenal medullary catecholamine production.  Shock. 2010;  33 213-217
• 7 Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM, Montori VM. The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.  J Clin Endocrinol Metab. 2008;  93 1526-1540
• 8 Lenders JW, Willemsen JJ, Eisenhofer G, Ross HA, Pacak K, Timmers HJ, Sweep CG. Is supine rest necessary before blood sampling for plasma metanephrines?.  Clin Chem. 2007;  53 352-354
• 9 Peaston RT, Graham KS, Chambers E, van der Molen JC, Ball S. Performance of plasma free metanephrines measured by liquid chromatography-tandem mass spectrometry in the diagnosis of pheochromocytoma.  Clin Chim Acta. 2010;  411 546-552
• 10 Lenders JW, Eisenhofer G, Mannelli M, Pacak K. Phaeochromocytoma.  Lancet. 2005;  366 665-675
• 11 Wurtman RJ. Control of epinephrine synthesis in the adrenal medulla by the adrenal cortex: hormonal specificity and dose-response characteristics.  Endocrinology. 1966;  79 608-614
• 12 Goodman R, Edgar D, Thoenen H, Wechsler W, Herschman H. Glucocorticoid induction of tyrosine hydroxylase in a continuous cell line of rat pheochromocytoma.  J Cell Biol. 1978;  78 R1-R7
• 13 Critchley JA, Henderson CG, Moffat LE, Ungar A, Waite J, West CP. Proceedings: The release of catecholamines from perfused canine adrenal glands by corticosteroids.  J Physiol. 1976;  254 30P-31P
• 14 Park YS, Ha CY, Park CH, Kim KT. Nongenomic glucocorticoid effects on activity-dependent potentiation of catecholamine release in chromaffin cells.  Endocrinology. 2008;  149 4921-4927
• 15 Wong S, Tan K, Carey KT, Fukushima A, Tiganis T, Cole TJ. Glucocorticoids stimulate hepatic and renal catecholamine inactivation by direct rapid induction of the dopamine sulfotransferase Sult1d1.  Endocrinology. 2010;  151 185-194
• 16 Wurtman RJ, Axelrod J. Adrenaline synthesis: control by the pituitary gland and adrenal glucocorticoids.  Science. 1965;  150 1464-1465
• 17 Wong DL, Siddall B, Wang W. Hormonal control of rat adrenal phenylethanolamine N-methyltransferase. Enzyme activity, the final critical pathway.  Neuropsychopharmacology. 1995;  13 223-234
• 18 Viskupic E, Kvetnansky R, Sabban EL, Fukuhara K, Weise VK, Kopin IJ, Schwartz JP. Increase in rat adrenal phenylethanolamine N-methyltransferase mRNA level caused by immobilization stress depends on intact pituitary-adrenocortical axis.  J Neurochem. 1994;  63 808-814
• 19 Betito K, Diorio J, Meaney MJ, Boksa P. Adrenal phenylethanolamine N-methyltransferase induction in relation to glucocorticoid receptor dynamics: evidence that acute exposure to high cortisol levels is sufficient to induce the enzyme.  J Neurochem. 1992;  58 1853-1862
• 20 Betito K, Diorio J, Boksa P. Brief cortisol exposure elevates adrenal phenylethanolamine N-methyltransferase after a necessary lag period.  Eur J Pharmacol. 1993;  238 273-282
• 21 Tischler AS, Perlman RL, Morse GM, Sheard BE. Glucocorticoids increase catecholamine synthesis and storage in PC12 pheochromocytoma cell cultures.  J Neurochem. 1983;  40 364-370
• 22 Liu J, Heikkila P, Voutilainen R, Karonen SL, Kahri AI. Pheochromocytoma expressing adrenocorticotropin and corticotropin-releasing hormone; regulation by glucocorticoids and nerve growth factor.  Eur J Endocrinol. 1994;  131 221-228
• 23 Pacak K, Eisenhofer G, Grossman A. The incidentally discovered adrenal mass.  N Engl J Med. 2007;  356 2005
• 24 Young Jr WF. Adrenal causes of hypertension: pheochromocytoma and primary aldosteronism.  Rev Endocr Metab Disord. 2007;  8 309-320

Correspondence